Inovio Pharmaceuticals is trading 5.2% down now at $1.19, amid broader market pressure.
- It opened below the September 11 close of $1.25.
- No fresh company-specific announcement or earnings release was identified for September 14, 2026.
- Recent coverage focuses on the October 30 FDA decision for INO-3107; broader indexes are modestly lower, with risk sentiment pressured by elevated oil prices, Treasury yields, and rate-hike expectations.